It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Widely prescribed drugs recommended as first-line therapy for chronic obstructive pulmonary disease, or COPD — the USA's fourth-leading killer — raise the risk of heart attacks, strokes and death from heart disease, a study suggests.
Looking at stroke risk alone, the researchers did not find a statistically significant elevated risk with tiotropium or ipratropium. But the 53% increased risk of heart attack and the 80% increased risk of cardiovascular death were statistically significant, the authors write in this week's issue of the Journal of the American Medical Association.
Originally posted by VIKINGANT
How can you win? You get diagnosed with a respitory illness only to be given medication that can result in a coronary illness.